HomeAI · summaries
Storia in 2 fonti
Roche drug sets new standard for KRAS-driven lung cancer
Biotech's bull market, Vertex's gene therapy expansion, and more news from The Readout
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
statnews.com
Investors double down on Bain-backed startup
FDA's top gene therapy regulator steps down, Trump's plan to lower GLP-1 prices, and more biotech news
- ·
biopharmadive.com
BridgeBio gets funding for drug launch; United buys into cell therapy
Elsewhere, Otsuka’s kidney drug hit the goal of a confirmatory trial and Vertex’s CRISPR sickle cell drug secured expanded approval.
